Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isoliquiritigenin inhibits the proliferation, migration and metastasis of Hep3B cells via suppressing cyclin D1 and PI3K/AKT pathway
Yun Huang, Chen Liu, Wu-Cha Zeng, et al.
Bioscience Reports (2020) Vol. 40, Iss. 1
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Recent progress in treatment of hepatocellular carcinoma.
Zhiqian Chen, Hao Xie, Mingming Hu, et al.
PubMed (2020) Vol. 10, Iss. 9, pp. 2993-3036
Closed Access | Times Cited: 256
Perspectives on the Role of Isoliquiritigenin in Cancer
Kai-Lee Wang, Ying-Chun Yu, Shih‐Min Hsia
Cancers (2021) Vol. 13, Iss. 1, pp. 115-115
Open Access | Times Cited: 107
MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21
Anna E. Vilgelm, Nabil Saleh, Rebecca L. Shattuck-Brandt, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 505
Open Access | Times Cited: 99
Effect and mechanism of PI3K/AKT/mTOR signaling pathway in the apoptosis of GC-1 cells induced by nickel nanoparticles
Yongya Wu, Jun Ma, Yufei Sun, et al.
Chemosphere (2020) Vol. 255, pp. 126913-126913
Closed Access | Times Cited: 49
Pharmacological Effects and Underlying Mechanisms of Licorice-Derived Flavonoids
Yufan Wu, Zhuxian Wang, Qunqun Du, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-25
Open Access | Times Cited: 30
Research progress of traditional Chinese medicine compound "Xiaochaihu Decoction" in the treatment of depression
Chunyan Sun, Mingzhou Gao, Mingqi Qiao
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114249-114249
Open Access | Times Cited: 17
Identification of a New Pentafluorosulfanyl-Substituted Chalcone with Activity Against Hepatoma and Human Parasites
Alessandra Viperino, Michael Höpfner, Nicole Edel, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 50-50
Open Access
Wogonoside alleviates the proliferation and promotes the apoptosis in liver cancer cells by regulating PI3K/Akt signaling pathway
Xinfang Li, Yitong Huang, Yibo He, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents
Jiahui Yang, Jianmei Lv, Shuxian Cheng, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 11, pp. 1265-1283
Closed Access | Times Cited: 10
Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects
Hardeep Singh Tuli, Vivek Kumar Garg, Jinit K Mehta, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 1419-1448
Open Access | Times Cited: 17
HMOX1 promotes lung adenocarcinoma metastasis by affecting macrophages and mitochondrion complexes
Bo Chen, Liyang Zhang, Hongshu Zhou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Isoliquiritigenin-infused electrospun nanofiber inhibits breast cancer proliferation and invasion through downregulation of PI3K/Akt/mTOR and MMP2/9 pathways
Kumar Ganesan, Fei Gao, Chuan Zheng, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105609-105609
Closed Access | Times Cited: 2
BCLAF1 induces cisplatin resistance in lung cancer cells
Tao Jiang, Bingjie Liu, Dongping Wu, et al.
Oncology Letters (2020) Vol. 20, Iss. 5, pp. 1-1
Open Access | Times Cited: 21
Structure-Based Profiling of Potential Phytomolecules with AKT1 a Key Cancer Drug Target
Zeenat Mirza, Sajjad Karim
Molecules (2023) Vol. 28, Iss. 6, pp. 2597-2597
Open Access | Times Cited: 6
Chalcone Derivatives and their Activities against Drug-resistant Cancers: An Overview
Jiaqi Xiao, Meixiang Gao, Qiang Diao, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 21, Iss. 5, pp. 348-362
Closed Access | Times Cited: 16
The Potential of Glycyrrhiza from “Medicine Food Homology” in the Fight against Digestive System Tumors
Doudou Lu, Yating Yang, Yuhua Du, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7719-7719
Open Access | Times Cited: 5
Flavonoids in natural products for the therapy of liver diseases: progress and future opportunities
Yanmei Liao, Fei Lv, Tianwen Quan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Identification of Immune-Related Prognostic mRNA and lncRNA in Patients with Hepatocellular Carcinoma
Dan Chen, Xiaoting Li, Hui Li, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 8
Isoliquiritigenin regulates the circ_0002860/miR-431-5p/RAB9A axis to function as a tumor inhibitor in melanoma
Songjiang Wu, Jian Wang
˜The œJournal of venomous animals and toxins including tropical diseases (2023) Vol. 29
Open Access | Times Cited: 4
Material basis research for Echinacea purpurea (L.) Moench against hepatocellular carcinoma in a mouse model through integration of metabonomics and molecular docking
Wenqian Xu, Bin Hu, Yuliang Cheng, et al.
Phytomedicine (2022) Vol. 98, pp. 153948-153948
Closed Access | Times Cited: 6
Oncopreventive and Oncotherapeutic Potential of Licorice Chalcone Compounds: Molecular Insights
Yushu Wang, Wenxin Xia, Mengxin Tao, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 6, pp. 662-699
Closed Access | Times Cited: 5
The Voyage of Natural Chalcone: Isoliquiritigenin
Himanshu Rani
Current Bioactive Compounds (2023) Vol. 20, Iss. 1
Closed Access | Times Cited: 2
<p>Overexpression of Rab40b Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway</p>
Liwei Shi, Zhibo Zhao, Li Zhong, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 10139-10150
Open Access | Times Cited: 6
An insight into the therapeutic effects of isoliquiritigenin in breast cancer
Divya Sharma, Mahaveer Dhobi, Viney Lather, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9503-9519
Closed Access
Isoliquiritigenin: A natural compound with a promising role in inhibiting breast cancer lung metastasis
Kumar Ganesan, Cong Xu, Bing Du, et al.
Journal of Traditional and Complementary Medicine (2024)
Open Access
Page 1 - Next Page

Scroll to top